Aligos Therapeutics, Inc. Common Stock
ALGS
ALGS: Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
moreShow ALGS Financials
Recent trades of ALGS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ALGS's directors and management
Government lobbying spending instances
-
$110,000 Jul 20, 2023 Issue: Labor Issues/Antitrust/Workplace
-
$110,000 Apr 20, 2023 Issue: Labor Issues/Antitrust/Workplace
New patents grants
-
Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
-
Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
-
Patent Title: Methods of reducing virus molecule levels Mar. 28, 2023
-
Patent Title: Bicyclic and tricyclic compounds Feb. 28, 2023
-
Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Jan. 10, 2023
-
Patent Title: Modified gapmer oligonucleotides and methods of use Oct. 11, 2022
-
Patent Title: Heterocyclic compounds Oct. 11, 2022
-
Patent Title: Compounds targeting prmt5 Dec. 14, 2021
-
Patent Title: Pyrrole compounds Dec. 07, 2021
-
Patent Title: S-antigen transport inhibiting oligonucleotide polymers and methods Nov. 09, 2021
-
Patent Title: Tricyclic compounds Oct. 05, 2021
-
Patent Title: Modulators of thr-β and methods of use thereof Aug. 17, 2021
-
Patent Title: Bicyclic sulfonamides Jun. 15, 2021
Federal grants, loans, and purchases
Followers on ALGS's company Twitter account
Number of mentions of ALGS in WallStreetBets Daily Discussion
Recent insights relating to ALGS
Recent picks made for ALGS stock on CNBC
ETFs with the largest estimated holdings in ALGS
Flights by private jets registered to ALGS